UNSPSC 51283511: Dicloxacillin sodium monohydrate

This classification denotes a penicillin antibiotic with the molecular formula C19H16Cl2N3O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4HZT2V9KX0, chemically known as 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but more generally known as dicloxacillin sodium, which bears US NIH Compound Identifier 6098.

European Medicines Agency schedules Dicloxacillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11900MIG. Most nations, for tariff and trade purposes, schedule dicloxacillin sodium monohydrate under HS 29411090 and SITC 54131. SMILES: CC1C(C(NO1)C2C(CCCC2CL)CL)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].

UNSPSC 51283511 Dicloxacillin sodium monohydrate is a Commodity code representing pharmaceutical active ingredients and finished-dose antibiotics purchased by state and local health agencies for public health stockpiling, emergency preparedness, and community health programs. Recent state and local solicitations under this code show procurement of branded antibiotics and emergency-response pharmaceuticals rather than dicloxacillin specifically, indicating that state and local agencies use this code to classify broad-spectrum antibiotic procurement within their emergency medical supply and public health inventories. Issuing bodies include state departments of public health and county health departments, which acquire these products through competitive bidding processes, piggyback contracts with cooperative purchasing consortiums such as MMCAP, and fixed-fee arrangements with quarterly or on-demand delivery schedules.

Activity concentrates in Florida and Illinois based on recent awards and open solicitations. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets with a 12-month initial term and two-year renewal options. Seminole County, Florida issued an IFB in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, requiring vendor-borne shipping costs and a two-year initial term with one-year renewal option. Both procurements emphasized electronic bidding, drug-free workplace certification, E-Verify compliance, and fixed unit pricing; the Seminole County procurement flagged potential FEMA funding with associated federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act.